Skip to main content

Reimbursement

17
Nov 2022

2023 Swedish procedure coding system (KVÅ) released

In November 2022, an annual update of the Swedish procedure coding system (Classification of Health Care Measures, KVÅ) was released to come into force from January 2023. A total of 119 new surgical procedure codes and 98 new medical procedure codes will be introduced concerning cardiovascular, diagnostic imaging, eHealth, endocrinology, endoscopy, ENT, gastrointestinal, IVD, nephrology and urology, peripheral vascular, and others.
15
Nov 2022

New procedure codes added to the French CCAM Nomenclature

On November 3, 2022, the decision of the National Union of Health Insurance Funds relating to the update of the CCAM Nomenclature of procedure codes was published in the Official Journal of the French Republic. Four new procedure codes were introduced. The codes relate to the procedures of implantation and removal of the bone conduction hearing aid and destruction of bronchopulmonary tumors by radiofrequency.
10
Nov 2022

Recommendations about add-on reimbursement for medical devices in France in October 2022

The French National Authority for Health released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies in October 2022. Fourteen recommendations were published in relation to the registration, modification of registration conditions, and renewal of registration for devices in the List of reimbursable products and services. Opinions concern cardiovascular, neurovascular, orthopedic, and ENT devices, as well as medical aids.
27
Oct 2022

Three more health apps obtained reimbursement in Germany

In late September – early October 2022, three more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by sickness funds.
26
Oct 2022

Dutch Healthcare Authority published the second release of the 2023 DRG package

On September 22, 2022, the Dutch Healthcare Authority (NZa) published the second release of the DRG package for 2023 (RZ23b). Nineteen new procedure codes, eight new supplementary payments, and seven new DRGs will be implemented. These changes concern remote monitoring, molecular diagnostics, surgical procedures, gynecology and dermatology technology groups.
24
Oct 2022

Rehabilitation using a health app in the primary knee or hip replacement is now available to all eligible patients in Belgium

Rehabilitation before or after a primary knee or hip replacement using a health app is temporarily reimbursed in Belgium under a specific agreement with the National Institute for Health and Disability Insurance (INAMI-RIZIV). Reimbursement was limited to patients participating in the clinical study. From October 01, 2022, all patients eligible for rehabilitation before and after a primary knee or hip replacement will receive it using a health app in combination with a certain minimum number of classic face-to-face physiotherapy sessions. Certain health apps must be included in the list of reimbursable mobile applications. For now, only one app (MoveUP Coach) is included.
21
Oct 2022

The 2023 procedure coding system (NCMP-NCSP-NCRP) released in Norway

In October 2022, the Norwegian Directorate of e-Health released the procedure coding system for 2023. A total of 54 new codes will be introduced from January 2023: 19 surgical procedure codes (NCSP) concerning neurology and neurosurgery, neurovascular, cardiovascular, eHealth, diagnostic imaging, pulmonary and airwaves, radiotherapy, nephrology, peripheral vascular, and surgical procedures, 17 radiology procedure codes (NCRP), and 18 medical procedure codes (NCMP).
20
Oct 2022

NHS Genomic Strategy for 2023-2028 released in England

On March 16, 2022, NHS England launched a strategy for embedding genomics in the NHS over the next five years. The ambition is to accelerate the use of genomic medicine across the NHS, providing a world-leading, equitable service to populations and individuals.